Cargando…
In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod
We evaluated the in silico expression and circulating levels of interleukin (IL)37 in patients with different forms of multiple sclerosis (MS) and also upon treatment with different disease-modifying drugs. The combined interpretation of the resulting data strengthens and extends the current emergin...
Autores principales: | Cavalli, Eugenio, Mazzon, Emanuela, Basile, Maria Sofia, Mammana, Santa, Pennisi, Manuela, Fagone, Paolo, Kalfin, Reni, Martinovic, Vanja, Ivanovic, Jovana, Andabaka, Marko, Mesaros, Sarlota, Pekmezovic, Tatjana, Drulovic, Jelena, Nicoletti, Ferdinando, Petralia, Maria Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982851/ https://www.ncbi.nlm.nih.gov/pubmed/31861585 http://dx.doi.org/10.3390/molecules25010020 |
Ejemplares similares
-
COVID-19 and vaccination against SARS-CoV-2 in patients with neuromyelitis optica spectrum disorders
por: Jovicevic, Vanja, et al.
Publicado: (2022) -
Humoral response to SARS-CoV-2 COVID-19 vaccines in patients with multiple sclerosis treated with immune reconstitution therapies
por: Drulovic, Jelena, et al.
Publicado: (2021) -
Humoral response to SARS-CoV-2 infection and vaccines against COVID-19 in patients with neuromyelitis optica spectrum disorders: Impact of immunosuppressive treatment
por: Jovicevic, Vanja, et al.
Publicado: (2022) -
The Role of Macrophages in Neuroinflammatory and Neurodegenerative Pathways of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis, and Multiple Sclerosis: Pathogenetic Cellular Effectors and Potential Therapeutic Targets
por: Mammana, Santa, et al.
Publicado: (2018) -
Gene Co-Expression Network Modular Analysis Reveals Altered Immune Mechanisms in HIV-HAND
por: Petralia, Maria Cristina, et al.
Publicado: (2022)